Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.
Green TC, Case P, Fiske H, Baird J, Cabral S, Burstein D, Schwartz V, Potter N, Walley AY, Bratberg J. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2S):S19-S27.e4. PMID: 28214219.

View in: PubMed

collapse authors with profiles